[HTML][HTML] Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)

ZA Sherif, CR Gomez, TJ Connors, TJ Henrich… - Elife, 2023 - elifesciences.org
COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

[HTML][HTML] Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer's disease, Parkinson's disease, and long-COVID through NRF2 activation to …

T Satoh, D Trudler, CK Oh, SA Lipton - Antioxidants, 2022 - mdpi.com
Rosemary (Rosmarinus officinalis [family Lamiaceae]), an herb of economic and gustatory
repute, is employed in traditional medicines in many countries. Rosemary contains carnosic …

SARS‐COV‐2 infection and Parkinson's disease: possible links and perspectives

HM Al‐kuraishy, AI Al‐Gareeb… - Journal of …, 2023 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive
loss of dopaminergic neurons in the substantia nigra. The hallmarks are the presence of …

[HTML][HTML] Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy?

G Azar, S Bonnin, V Vasseur, C Faure, F Salviat… - Journal of clinical …, 2021 - mdpi.com
Background: Acute macular neuroretinopathy (AMN) is an increasingly diagnosed disorder
associated with several diseases. The aim of this study was to report the incidence of AMN …

[HTML][HTML] Beneficial and detrimental functions of microglia during viral encephalitis

I Waltl, U Kalinke - Trends in Neurosciences, 2022 - cell.com
Microglia are resident immune cells of the central nervous system (CNS) with multiple
functions in health and disease. Their response during encephalitis depends on whether …

[HTML][HTML] NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes

D Dutta, J Liu, H Xiong - International journal of physiology …, 2022 - ncbi.nlm.nih.gov
Despite the introduction of vaccines and drugs for SARS-CoV-2, the COVID-19 pandemic
continues to spread throughout the world. In severe COVID-19 patients, elevated levels of …

[HTML][HTML] Mitogen activated protein kinase (MAPK) activation, p53, and autophagy inhibition characterize the severe acute respiratory syndrome coronavirus 2 (SARS …

AM Kyriakopoulos, G Nigh, PA McCullough, S Seneff - Cureus, 2022 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and
prions use common pathogenic pathways to induce toxicity in neurons. Infectious prions …

[HTML][HTML] COVID-19 and parkinsonism: a critical appraisal

F Cavallieri, V Fioravanti, F Bove, E Del Prete, S Meoni… - Biomolecules, 2022 - mdpi.com
A few cases of parkinsonism linked to COVID-19 infection have been reported so far, raising
the possibility of a post-viral parkinsonian syndrome. The objective of this review is to …

SARS-CoV-2-mediated neuropathogenesis, deterioration of hippocampal neurogenesis and dementia

RK Radhakrishnan… - American Journal of …, 2022 - journals.sagepub.com
A significant portion of COVID-19 patients and survivors display marked clinical signs of
neurocognitive impairments. SARS-CoV-2-mediated peripheral cytokine storm and its …

[HTML][HTML] Microglial Inflammatory Responses to SARS‐CoV‐2 Infection: A Comprehensive Review

R Dey, B Bishayi - Cellular and Molecular Neurobiology, 2024 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is primarily a respiratory disease causing a
worldwide pandemic in the year of 2019. SARS‐CoV‐2 is an enveloped, positive-stranded …